322 related articles for article (PubMed ID: 26505137)
21. Emerging Roles of Purinergic Signaling in Diabetes.
Fotino C; Dal Ben D; Adinolfi E
Med Chem; 2018; 14(5):428-438. PubMed ID: 29485002
[TBL] [Abstract][Full Text] [Related]
22. Adenylate cyclase 5 coordinates the action of ADP, P2Y1, P2Y13 and ATP-gated P2X7 receptors on axonal elongation.
del Puerto A; Díaz-Hernández JI; Tapia M; Gomez-Villafuertes R; Benitez MJ; Zhang J; Miras-Portugal MT; Wandosell F; Díaz-Hernández M; Garrido JJ
J Cell Sci; 2012 Jan; 125(Pt 1):176-88. PubMed ID: 22250198
[TBL] [Abstract][Full Text] [Related]
23. miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.
Salim H; Arvanitis A; de Petris L; Kanter L; Hååg P; Zovko A; Özata DM; Lui WO; Lundholm L; Zhivotovsky B; Lewensohn R; Viktorsson K
Genes Chromosomes Cancer; 2013 Oct; 52(10):895-911. PubMed ID: 23929716
[TBL] [Abstract][Full Text] [Related]
24. Association between Th17-related cytokines and risk of non-small cell lung cancer among patients with or without chronic obstructive pulmonary disease.
Liao C; Yu ZB; Meng G; Wang L; Liu QY; Chen LT; Feng SS; Tu HB; Li YF; Bai L
Cancer; 2015 Sep; 121 Suppl 17():3122-9. PubMed ID: 26331819
[TBL] [Abstract][Full Text] [Related]
25. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
[TBL] [Abstract][Full Text] [Related]
27. [Expression of endoglin in human non-small cell lung cancer and its clinical significance].
Li M; Lu S; Liu X; Zhao J; Zhang H; Ling C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):581-4. PubMed ID: 23746240
[TBL] [Abstract][Full Text] [Related]
28. Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.
Jalkanen J; Yegutkin GG; Hollmén M; Aalto K; Kiviniemi T; Salomaa V; Jalkanen S; Hakovirta H
Circ Res; 2015 Mar; 116(7):1206-15. PubMed ID: 25645301
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].
Huang F; Wang XL; Geng Y; Li MX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):507-9. PubMed ID: 15989803
[TBL] [Abstract][Full Text] [Related]
30. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
31. IL-17C mediates the recruitment of tumor-associated neutrophils and lung tumor growth.
Jungnickel C; Schmidt LH; Bittigkoffer L; Wolf L; Wolf A; Ritzmann F; Kamyschnikow A; Herr C; Menger MD; Spieker T; Wiewrodt R; Bals R; Beisswenger C
Oncogene; 2017 Jul; 36(29):4182-4190. PubMed ID: 28346430
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
[TBL] [Abstract][Full Text] [Related]
33. P2Y
Morrone FB; Vargas P; Rockenbach L; Scheffel TB
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684726
[TBL] [Abstract][Full Text] [Related]
34. Lung tissue and tumour-infiltrating T lymphocytes in patients with non-small cell lung carcinoma and chronic obstructive pulmonary disease (COPD): moderate/severe versus mild stage of COPD.
Marc MM; Korosec P; Kern I; Sok M; Ihan A; Kosnik M
Scand J Immunol; 2007 Dec; 66(6):694-702. PubMed ID: 17949407
[TBL] [Abstract][Full Text] [Related]
35. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract][Full Text] [Related]
36. Towards effective immunotherapy for lung cancer: simultaneous targeting of tumor-initiating cells and immune pathways in the tumor microenvironment.
Dubinett S; Sharma S
Immunotherapy; 2009 Sep; 1(5):721-5. PubMed ID: 20636013
[No Abstract] [Full Text] [Related]
37. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
[TBL] [Abstract][Full Text] [Related]
38. Extracellular purines, purinergic receptors and tumor growth.
Di Virgilio F; Adinolfi E
Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
[TBL] [Abstract][Full Text] [Related]
39. Purinergic Signaling Within the Tumor Microenvironment.
Draganov D; Lee PP
Adv Exp Med Biol; 2021; 1270():73-87. PubMed ID: 33123994
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]